Overview

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
A study of pharmacokinetics of daily intravenous busulfan
Phase:
N/A
Details
Lead Sponsor:
Alberta Health Services
Treatments:
Busulfan
Fludarabine
Fludarabine phosphate